跳至主要内容
临床试验/NCT07279012
NCT07279012已完成不适用

Exploring the Potential of Minimally Invasive Le Fort I Approach to Enhance Patient Outcomes

TC Erciyes University2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2022年2月24日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
2
主要终点
Operative Time

研究概览

简要总结

This is a single-center, prospective, randomized, controlled, and double-blind clinical study designed to evaluate the clinical outcomes of the minimally invasive Le Fort I osteotomy (MI-Le Fort I) compared with the conventional Le Fort I osteotomy (Le Fort I) in patients undergoing orthognathic surgery.

Patients aged 18 to 40 years, classified as ASA I, will be randomly assigned to one of two groups: the MI-Le Fort I group or the Le Fort I group. Intraoperative parameters including blood loss (mL) and operative time (minutes) will be recorded. Postoperative facial swelling will be assessed using three-dimensional stereophotogrammetry, pain intensity will be measured with a visual analog scale (VAS). Additional outcomes will include hospitalization time, early recovery of upper lip sensation assessed by the pinprick test, and pterygomaxillary separation patterns evaluated using postoperative CBCT imaging.

The aim of this study is to compare the clinical outcomes of the MI-Le Fort I approach with the Le Fort I approach under controlled conditions. The study hypothesizes that the MI-Le Fort I osteotomy improves patient outcomes by minimizing soft tissue trauma without compromising surgical effectiveness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who underwent Le Fort I osteotomy for maxillary dentofacial deformity
  • Patients classified as ASA I
  • Patients over 18 years of age

排除标准

  • Patients with uncontrolled diabetes
  • Patients with metabolic bone diseases (e.g., hyperparathyroidism, Paget's disease)
  • Patients with syndromic conditions (e.g., Pierre Robin syndrome, Treacher Collins syndrome)
  • Patients who had previously undergone maxillary surgery due to trauma, tumors, or cysts and had sequelae involving the upper jaw
  • Patients with a history of previous orthognathic surgery

研究组 & 干预措施

Minimally Invasive Le Fort I Osteotomy

Experimental

干预措施: Minimally Invasive Le Fort I Osteotomy (Procedure)

Conventional Le Fort I Osteotomy

Active Comparator

干预措施: Conventional Le Fort I Osteotomy (Procedure)

结局指标

主要结局

Operative Time

时间窗: Intraoperative period (from mucosal incision to final suture placement)

Operative time will be measured in minutes, from the initial mucosal incision to the final suture placement, using a chronometer.

Bleeding

时间窗: Intraoperative period (from mucosal incision to final suture placement)

Bleeding volume will be measured in milliliters from the initial mucosal incision to the final suture placement, using a calibrated aspirator.

Postoperative Edema

时间窗: Postoperative days 1, 7, 14, 30 and 90

The 3dMD imaging system (3dMD, Atlanta, GA, USA) and 3dMD Vultus software were used to evaluate the amount of postoperative edema. Three-dimensional images were taken with the teeth in maximum intercuspation, lips relaxed, and eyes open on postoperative days 1, 7, 14, 30, and 90. Edema was calculated separately for the right and left sides and was recorded as surface area in square centimeters (cm²).

Postoperative Pain

时间窗: Postoperative hours 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12

Postoperative pain was evaluated using the Visual Analogue Scale for the right and left sides separately. In this scale, '0' meant no pain, and '100' represented maximum pain. Patients were questioned at postoperative 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th and 12th hours, and the results were recorded in the patient follow-up form.

次要结局

  • Hospitalization(From the end of surgery until hospital discharge (typically within 48 hours))
  • Pterygomaxillary Separation Pattern(Postoperative first day)
  • Neurosensory Test: Upper Lip Sensation Recovery(Postoperative days 7, 14, and 30)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

İbrahim Mert Erkan

resident

TC Erciyes University

研究点 (2)

Loading locations...

相似试验